Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71839-108

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 71839-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Daptocartonlabel1vial (Daptocartonlabel1vial)

Daptocartonlabel1vial (Daptocartonlabel1vial)
This is a drug called Daptomycin, which must be refrigerated and reconstituted with 7 mL of 0.9% sodium chloride injection to obtain a final concentration of 50 mg per mL. It is for intravenous use only and comes in single-dose vials containing 350 mg of the drug. The text also includes a lot number and a code to identify the product.*
FDA Label Image

Daptostr (Daptostr)

FDA Label Image

Daptoviallabel (Daptoviallabel)

Daptoviallabel (Daptoviallabel)
This is a description of a pharmaceutical product with NDC 71839-108-01. It provides instructions to reconstitute the product with 7mL of sodium chloride injection to obtain a final concentration of 50 mg per mL. The product is sterile, non-pyrogenic, made in India, preservative-free, and does not contain natural rubber latex. It must be refrigerated between 2° and 8°C (36° and 46° F) and should be discarded after a single use. The Lot and Exp numbers are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.